We are looking for children and teenagers 2–17 years of age to join a CD study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea with blood and pus, mouth sores, constant need to poop, frequent fevers and/or canker sores), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

We are looking for young people 2 to 17 years of age to join a clinical research to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe UC (including associated symptoms such as abdominal pain and cramps, growth failure, diarrhea, chronic fatigue and/or liver disease), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing Crohn’s and UC flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce abdominal pain and cramps, joint pain, diarrhea, weight loss, and/or joint pain associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local CD study is testing a potential new medication to see if it may reduce painful joints, inflammation of the bowel or intestine, bloody stool, frequent fevers, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children and teens 2–17 years of age to join a Crohn’s disease (CD) clinical research study to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderately to severely active ulcerative colitis (including associated symptoms such as diarrhea with pus, joint pain, constant need to poop, malnutrition and/or eye pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

We are looking for 2 to 17 years old to join a Crohn’s disease clinical research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea, joint pain, rectal pain, malnutrition and/or canker sores), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing CD and UC flare-ups? Local clinical research is testing a potential new medication to see if it may reduce recurrent diarrhea, loss of appetite, diarrhea, weight loss, and/or eye pain associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children at least 2 years of age but under 18 to join a CD clinical research to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or Crohn’s disease (CD) (including associated symptoms such as rectal pain, joint pain, cramps, weight loss and/or eye pain), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

We are looking for children 2–17 years old to join a Crohn’s disease clinical research study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or UC (including associated symptoms such as long-term diarrhea, persistent diarrhea, diarrhea, frequent fevers and/or liver disease), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing gastrointestinal disease flare-ups? Local Crohn’s disease (CD) study is testing a potential new medication to see if it may reduce stomach pain, blood in the stool, abdominal pain, weight loss, and/or joint pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the Crohn’s disease (CD) study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.